Long-Term Treatment With BRAF/MEK Inhibitors for Pleomorphic Xanthoastro- cytoma Grade 3: A Case Report
1. Abstract 1.1. Background Pleomorphic xanthoastrocytoma grade 3 is rare disease classified as a distinct entity in WHO classification 2016. It is usually refractory to a standard therapy for high grade gliomas and has a dismal prognosis.

